1-phthalidyl-5-fluorouracil has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Taguchi, T; Terasawa, T | 1 |
2 other study(ies) available for 1-phthalidyl-5-fluorouracil and Breast Neoplasms
Article | Year |
---|---|
[Pharmacokinetic studies of a new fluorinated pyrimidine, 590-S (PH-FU), in human patients].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Female; Fluorouracil; Humans; Kinetics; Male; Middle Aged; Stomach Neoplasms | 1986 |
[A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Middle Aged | 1987 |